Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
about
Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival.Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.Fatal cytomegalovirus disease after combination therapy with corticosteroids and rituximab for granulomatosis with polyangiitis.Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysisEmerging therapies for herpes viral infections (types 1 - 8).Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation.Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience.
P2860
Q33374450-C87AE04A-EA5D-4DB4-9197-638181DCA6D9Q33410582-8FAC7B1C-2BFA-4940-A464-B2D9AD3E0AF6Q34034462-2AFE68E2-DC95-4D0D-987E-0BBC5FDE8841Q35034085-AA1631B8-AE97-445B-8CF2-C1FB4DDE7E13Q35900978-B2476927-DD8E-42FE-949A-9783B9613F8FQ35967376-D969B995-35B5-44ED-9288-FD25772D37E7Q36395715-9B1EB436-4B9D-4FD2-8234-AD0083762646Q36871982-F2EC2B53-03B1-40E3-B795-4581ECF43A73Q37148363-AD4A4DAF-0E5F-4906-932A-EA945FDC5F9AQ37683007-5603A6D2-96E9-4942-99F1-0FCFE55F8C09Q39949115-2446EFB6-D9D7-44C1-8E8F-8AF125C0A6CBQ40120411-F2A53D5B-A3FB-4F3C-AB64-1B4FEA0BDE3DQ42181212-D18A3659-881E-4614-B40A-7BDAFE5ADD22Q43112358-3910E2AB-A040-46BF-8BF5-868778075A46Q43735414-759E205D-9288-427F-9D03-A2C3AF466159
P2860
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@ast
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@en
type
label
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@ast
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@en
prefLabel
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@ast
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@en
P2093
P2860
P1476
Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
@en
P2093
Ellen Meijer
Greet J Boland
Leo F Verdonck
P2860
P304
P356
10.1128/CMR.16.4.647-657.2003
P407
P577
2003-10-01T00:00:00Z